Molecular Insight Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 0.7 | 0.3 | 1.2 |
| Cost of Goods Sold | -- | 16.6 | -- |
| Gross Profit | -- | (16.3) | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 57.7 | 9.9 | 19.7 |
| Depreciation & Amortization | 0.7 | 0.3 | 0.1 |
| Operating Income | (57.7) | (26.5) | (18.6) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 2.6 | 0.5 | 0.5 |
| Nonoperating Expenses | 4.7 | 1.2 | 0.1 |
| Income Before Taxes | (59.8) | (27.3) | (18.3) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (59.8) | (27.3) | (18.3) |
| Continuing Operations | (59.8) | (27.3) | (18.3) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (59.8) | (27.3) | (18.3) |
| Total Net Income | (59.8) | (27.3) | (18.3) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (2.65) | (7.18) | (5.30) |
| Dividends per Share | -- | -- | -- |





